The Norwegian naturalistic treatment study of depression in general practice (NORDEP)—I: Randomised double blind study

BMJ

Volumn 318, Issue 7192, 1999, Pages 1180-1184

  Malt, Ulrik F ^a   Robak, Ole Herman ^b   Madsbu, H P ^c   Bakke, O ^d   Loeb, M ^e  

^a UNIVERSITY OF OSLO   (Norway)

^b Psychiatric Centre of Northern Vestfold Holmestrand   (Norway)

^c Elverum legesenter ^*  (Norway)

^d Aust Agder Central Hospital   (Norway)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; PATIENT COUNSELING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RECURRENT DISEASE; REMISSION; SOCIAL SUPPORT;

EID: 0033134815     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.318.7192.1180     Document Type: Article

References (18)

1. Paykel ES, Priest RG. Recognition and management of depression in general practice: consensus statement. BMJ 1992; 305: 1198–1202.
2. Depression guideline panel. Depression in primary care. Vol 2. Treatment of major depression. Rockville: US Department of Health and Human Services, 1993.
3. Salokangas RKR, Poutanen O, Stengård E, Jähi R, Palo-oja T. Prevalence of depression among patients seen in community health centres and community mental health centres. Acta Psychiatr Scand 1996; 93: 427–433.
4. Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 322–329.
5. Bech P, Malt UF, Dencker SJ, Ahlfors UG, Elgen K, Lewander T, et al. Scales for the assessment of diagnosis and severity of mental disorders. Acta Psychiatr Scand 1993; 87(suppl 372).
6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd revision. Washington, DC: American Psychiatric Press, 1987.
7. World Health Organisation. The ICD-10 classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines. Geneva: WHO, 1992.
8. Alltman DG. Practical statistics for medical research. London: Chapman and Hall, 1991.
9. Lingjærde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand 1987; 76(suppl 334).
10. Fawcett J, Epstein P, Fiester SJ, Elkin I, Autry JH. Clinical management imipramine/placebo administration manual. Psychopharmacol Bull 1987; 23: 309–321.
11. Nordic Council on Medicines. Good clinical trial practice. NLN Publication No 28, Uppsala: Nordiska Läkemedelsnämden, 1989.
12. Mynors-Wallis LM, Gath DH, Lloyd-Thomas AR, Tomlison D. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ 1995; 310: 441–445.
13. Thase ME, Greenhouse JB, Frank E, Reynolds III CF, Pilkonis P, Hurley K, et al. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry 1997; 54: 1009–1015.
14. Soloman DA, Keller MB, Leon AC, Mueller TI, Shea MT, Warshsaw M, et al. Recovery from major depression: A 10-year prospective follow-up across multiple episodes. Arch Gen Psychiatry 1997; 54: 10001–10006.
15. Ekselius L, von Knorring L, Eberhard G. A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice. Int Clin Psychopharm 1997; 12: 323–331.
16. Coyne JC, Klinkman MS, Gallo SM, Schwenk T. Short-term outcomes of detected and undetected depressed primary care patients and depressed psychiatric patients. Gen Hosp Psychiatry 1997; 19: 333–343.
17. Lane R, Baldwin D, Preskorn SH. The SSRIs: advantages, disadvantages and differences. J Psychopharmacol 1995; 9(suppl 2): 163–178.
18. Montgomery SA. Fast-onset antidepressants. Intern Clin Psychopharm 1997; 12(suppl 3): 1–5S.